Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line.
Redox mechanisms function in regulation of cell growth, and variation in redox state of plasma thiol/disulfide couples occurs in various physiologic conditions, including diabetes, chemotherapy, and aging. The present study was designed to determine whether a systematic variation in extracellular thiol/disulfide redox state (E(h)) over a range (0 mV to -150 mV) that occurs in human plasma altered proliferation of cultured cells. Experiments were performed with a human colon carcinoma cell line (Caco2), which grows slowly in the absence of serum and responds to peptide growth factors with increased rate of cell division. The extracellular redox states were established by varying concentrations of cysteine and cystine, maintaining constant pool size in terms of cysteine equivalents. Incorporation of 5-bromo-2-deoxyuridine (BrdU) was used to measure DNA synthesis and was lowest at the most oxidized extracellular E(h) (0 mV). Incorporation increased as a function of redox state, attaining a 100% higher value at the most reduced condition (-150 mV). Addition of insulin-like growth factor-1 (IGF-1) or epidermal growth factor (EGF) increased the rate of BrdU incorporation at more oxidizing redox conditions (0 to -80 mV) but had no effect at -150 mV. Cellular GSH was not significantly affected by variation in extracellular E(h). In the absence of growth factors, extracellular E(h) values were largely maintained for 24 h. However, IGF-1 or EGF stimulated a change in extracellular redox to values similar to that for cysteine/cystine redox in plasma of young, healthy individuals. The results show that extracellular thiol/disulfide redox state modulates cell proliferation rate and that this control interacts with growth factor signaling apparently independently of cellular glutathione.
Jonas
Carolyn R
CR
Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
Ziegler
Thomas R
TR
Gu
Li H
LH
Jones
Dean P
DP
D001973:Bromodeoxyuridine / Q000494:pharmacology; D002455:Cell Division; D002851:Chromatography, High Pressure Liquid; D003470:Culture Media / Q000494:pharmacology; D003545:Cysteine / Q000378:metabolism; D003553:Cystine / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004220:Disulfides / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism*; D005609:Free Radicals; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D008954:Models, Biological; D010084:Oxidation-Reduction; D015398:Signal Transduction; D013997:Time Factors; D014407:Tumor Cells, Cultured
D003470:Culture Media; D004220:Disulfides; D005609:Free Radicals; D003553:Cystine; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D004247:DNA; D001973:Bromodeoxyuridine; D003545:Cysteine